OneAscent Financial Services LLC Boosts Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

OneAscent Financial Services LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,161 shares of the medical equipment provider’s stock after purchasing an additional 98 shares during the period. Intuitive Surgical makes up approximately 0.8% of OneAscent Financial Services LLC’s portfolio, making the stock its 26th biggest holding. OneAscent Financial Services LLC’s holdings in Intuitive Surgical were worth $1,062,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of ISRG. Ridgewood Investments LLC purchased a new position in shares of Intuitive Surgical in the 2nd quarter valued at $26,000. Godsey & Gibb Inc. raised its stake in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the period. Creekmur Asset Management LLC raised its stake in shares of Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares during the period. LGT Financial Advisors LLC raised its stake in shares of Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 54 shares during the period. Finally, MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical in the 3rd quarter valued at $33,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $482.21, for a total value of $90,655.48. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,655,048.26. This trade represents a 3.30 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 91,178 shares of company stock worth $45,897,071 in the last ninety days. 0.80% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. Piper Sandler reissued an “overweight” rating and issued a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. BTIG Research set a $535.00 price target on shares of Intuitive Surgical in a report on Friday, October 18th. Evercore ISI reaffirmed a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Citigroup raised their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Finally, Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $524.61.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $531.64 on Tuesday. Intuitive Surgical, Inc. has a one year low of $304.50 and a one year high of $544.38. The company has a 50-day simple moving average of $500.33 and a 200-day simple moving average of $459.58. The firm has a market capitalization of $189.36 billion, a PE ratio of 85.47, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Equities analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.